Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Identification of Antigens From Nosocomial Acinetobacter Baumannii Clinical Isolates in Sera From Icu Staff and Infected Patients Using the Antigenome Technique Publisher Pubmed



Nafarieh T1 ; Bandehpour M2 ; Hashemi A3 ; Taheri S3 ; Yardel V4 ; Jamaati H5 ; Moosavi SM6 ; Mosaffa N1
Authors

Source: World Journal of Microbiology and Biotechnology Published:2017


Abstract

Nosocomial infections with a bacterial origin are considered one of the most dangerous threats to global health. Among the causes of these infections, Acinetobacter baumannii is playing a significant role, and the present study aimed‏ to determine the immunogenic proteins of this bacteria. Clinical isolates of A. baumannii were obtained from positive sputum cultures of intensive care unit (ICU) patients confirmed by Polymerase chain reaction (PCR) of the OXA-51 gene, and sera was obtained from 20 colonized patients. In addition, 20 and 30 serum samples were collected from ICU nurses and healthy controls, respectively. All the samples were screened in the presence of antibodies against A. baumannii by enzyme-linked immunosorbent assay (ELISA). IgG purified from the serum samples by affinity chromatography was used to isolate the bacteria by the Magnetic-activated cell sorting (MACS) procedure. After the bacteria were cultured, the identified antigen proteins were studied by western blotting and Mass spectrometry (MS). The MS results were analyzed with MASCOT software and revealed a 35 KD protein, which corresponds to outer membrane protein A (OmpA) of A. baumannii, a 25 KD band, which is a carbapenem-associated resistance protein precursor, and a 60 KD protein band, identified as a stress-induced bacterial acidophilic repeat motif protein. According to the properties of immunogen antigens and bio informatics tools, the outer membrane proteins (OMPs) can be used as a vaccine candidate in animal models. © 2017, Springer Science+Business Media B.V.
Other Related Docs
11. Current Trends in Targeted Therapy for Drug-Resistant Infections, Applied Microbiology and Biotechnology (2019)